Impact case studies

Our NIHR Southampton Clinical Research Facility (NIHR CRF) plays a key role in driving new treatments and practice to the clinic, delivering research and commercial trials  driving new therapies and rapidly advancing patient health. 

Here you can discover more about the pioneering research taking place at the facility and learn more about the wide reaching impact of our work. 

Lynchpin in $220M fight against breathlessness infographic_110x110

Lynchpin in $220M fight against breathlessness

Our unit involved in the emergence of a $220M drug development programme aiming to minimise the impact of the common cold and other viruses on asthma and COPD sufferers. 

Read more


Enabling new antimicrobial therapies

Chronic lung infection in cystic fibrosis is a serious issue; our novel assays of bacterial biofilm degredation are one aspect of  our central role in biotech firm Antabio's €3.9million Wellcome Trust Seeding Drug Discovery award.

Read more

Wet AMD study infographic

Landmark study could save NHS £100 million

The facility was central to a UK-wide trial demonstrating that wet age-related macular degeneration (AMD) can be treated with a drug 10 times cheaper than the current treatment, representing a potential saving of £100 million per year.  

Read more